Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
Influenza and <i>S. pneumoniae</i> infections are a significant cause of morbidity and mortality worldwide. Intranasal live influenza vaccine (LAIV) may prevent influenza-related bacterial complications. The objectives of the study are to estimate resistance against early influenza infec...
Main Authors: | Yulia Desheva, Galina Leontieva, Tatiana Kramskaya, Igor Losev, Andrey Rekstin, Nadezhda Petkova, Polina Kudar, Alexander Suvorov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/10/6/1150 |
Similar Items
-
Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
by: Yulia Desheva, et al.
Published: (2022-12-01) -
Developing a Live Probiotic Vaccine Based on the <i>Enterococcus faecium</i> L3 Strain Expressing Influenza Neuraminidase
by: Yulia Desheva, et al.
Published: (2021-11-01) -
Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years
by: Yulia Desheva, et al.
Published: (2022-09-01) -
Factors of early protective action of live influenza vaccine combined with recombinant bacterial polypeptides against homologous and heterologous influenza infection
by: Yulia A. Desheva, et al.
Published: (2019-02-01) -
Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022-04-01)